NTRR 最新10-Q变化

相对上期新增的文字 · 来源:10-Q · 2024-08-07

• During the three months ended April 30, 2024, we recognized revenue of $32,375 and cost of goods sold of $1,420. For the three months ended April 30, 2024, revenue from consulting income from business development consulting services to one customer $29,420 and revenue from sales of CBD products tota…

• Interest expense was $867 and $199 for the three months ended April 30, 2024 and 2023, respectively.

• At April 30, 2024, we had cash on hand of $333. We have negative working capital of $987,030. Net cash used in operating activities for the three months ended April 30, 2024 was $1,299. The Company had net cash provided by investing and financing activities of $0 for the three months ended April 30,…

相对上期删除的文字 · 来源:10-Q · 2023-12-15

• During the three months ended October 31, 2023, we recognized revenue of $1,311 and cost of goods sold of $722 related to the sales of CBD products. During the three months ended October 31, 2022, we recognized revenue of $23,383 and cost of goods sold of $12,708 related to the sales of CBD products…

• Interest expense was $2,258 and $15,718 for the three months ended October 31, 2023, and 2022, respectively. The decrease in interest expense was related to the settlement of outstanding convertible notes payable in the prior year.

• Nine months ended October 31, 2023, compared to the nine months ended October 31, 2022.

• During the nine months ended October 31, 2023, we recognized revenue of $11,478 and cost of goods sold of $6,403 related to the sales of CBD products. During the nine months ended October 31, 2022, we recognized revenue of $62,077 and cost of goods sold of $29,725 related to the sales of CBD product…

• We recognized depreciation expense of $41,816 and $59,179 for the nine months ended October 31, 2023, and 2022 related to the Company’s property and equipment.